TABLE 1.
Glycocalyx-degrading agents in critical illness.
| Component | Degrading agent during critical illness | References |
| Hyaluronic acid | HYAL1, HYAL2, TMEM2, ROS | (17, 20–24) |
| Heparan sulfate | HYAL1, HEPase1, CTAP-III | (25–27, 29) |
| Chondroitin sulfate | HYAL4 | (30) |
| Syndecan-1 | MMP2,3,7,9, and 14, ADAM17 | (35, 37, 38) |
| Syndecan-4 | MMP2,3,7,9, and 14, ADAM17 | (37, 38) |
| CD44 | ADAM15, MMP14 | (36, 126) |
ADAM, a disintegrin and metalloproteinase; CTAP-III, connective tissue activating peptide-III; HEPase1, Heparanase-1; HYAL, hyaluronidase; MMP, matrix metalloproteinase; TMEM2, transmembrane 2; ROS, reactive oxygen species.